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Abstract— This study investigated the clinical feasibility of 
combining the electromechanical gait trainer Lokomat with 
functional electrical therapy (LokoFET), stimulating the 
common peroneal nerve during the swing phase of the gait cycle 
to correct foot drop as an integrated part of gait therapy. 
Five patients with different acquired brain injuries trained 
with LokoFET 2-3 times a week for 3-4 weeks. Pre- and post-
intervention evaluations were performed to quantify 
neurophysiological changes related to the patients’ foot drop 
impairment during the swing phase of the gait cycle. A semi-
structured interview was used to investigate the therapists’ 
acceptance of LokoFET in clinical practice. 
The patients showed a significant increase in the level of 
activation of the tibialis anterior muscle and the maximal 
dorsiflexion during the swing phase, when comparing the pre- 
and post-intervention evaluations. This showed an improvement 
of function related to the foot drop impairment. 
The interview revealed that the therapists perceived the 
combined system as a useful tool in the rehabilitation of gait. 
However, lack of muscle selectivity relating to the FES element 
of LokoFET was assessed to be critical for acceptance in clinical 
practice. 
I. INTRODUCTION 
Over a third of the patients suffering from acquired brain 
injury (ABI) have gait impairments [1], [2]. An inadequate 
control of dorsiflexion during the swing phase of gait (called 
foot drop) is often seen [3]. Foot drop is often caused by 
weakness of the tibialis anterior (TA) muscle [4], which can 
result in compensatory movement patterns [3], slowed gait 
velocity [5], limited functional mobility, and increased risk of 
falls [4]. 
Electromechanical gait trainers (EMGT) such as Lokomat 
(Hocoma AG, Volketwill, Switzerland) are often utilized to 
initiate early intensive gait rehabilitation [6]. Lokomat 
enables the patient to train gait movements with many 
repetitions, more independently of the therapist, potentially 
with their body weight supported, and with an automated 
movement of the lower extremities [6].  
Stroke patients subjected to EMGT therapy (using Lokomat) 
combined with conventional therapy develop larger muscle 
mass and lower fat percentage compared to controls only 
receiving conventional therapy [7]. Despite the beneficial 
effects of this EMGT therapy, Lokomat has shown to inhibit 
dorsiflexion of the ankle joint during the swing phase of the 
gait cycle, rather than facilitating it [8]. This conflicts with the 
guidelines for rehabilitation of pathological gait, which  
advocate that rehabilitation should facilitate a physiological 
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gait pattern, hereby supporting restorative neurorehabilitation 
[3]. 
Functional electrical stimulation (FES) administered at the 
common peroneal nerve has shown to facilitate dorsiflexion 
of the ankle joint during the swing phase of the gait cycle [9], 
and there is clinical evidence supporting FES having a 
therapeutic effect on the foot drop impairment [10]. 
The combination of EMGT and FES for rehabilitation of gait 
impairments in sub-acute stroke patients has resulted in 
increased gait speed compared to conventional  therapy [11]. 
However, only two studies have combined FES with 
Lokomat, showing that the combined system was technically 
feasible [12] and that when tested by one stroke patient, the 
patient was able to achieve better dorsiflexion and TA muscle 
activation during the swing phase of the gait cycle, in 
comparison to the normal gait pattern [13]. 
The goal of this feasibility study was therefore to test a 
clinical protocol combining Lokomat with Functional 
Electrical Therapy (FET), i.e. LokoFET, as preparation for 
larger clinical trials. The aims of the study were to: 
• quantify the neurophysiological changes related to the 
patient’s foot drop impairment after LokoFET treatment 
• investigate the therapists’ acceptance of LokoFET in 
clinical practice 
 
II. METHODS 
A. Test of LokoFET in clinical practice 
Subjects 
Five patients were recruited [Table I] based on the following 
inclusion criteria: suffering from ABI, age between 18-80 
years, weight 50-100kg, femur length 48-21cm, able to fully 
extend the knees, able to communicate and understand 
instructions, tolerate electric stimulation, tolerate to be 
supported passively in the body weight support (BWS) 
harness for 5 min, decreased dorsiflexion during the swing 
phase, and able to walk a minimum of 30 steps with the 
ankle strap from Lokomat in neutral position. Patients with 
the following criteria were excluded: height over 2 m, leg 
length difference > 2 cm, bone instability, infection and/or 
orthopedic problems in the placement area of the electrodes, 
heart or lung disease, pregnancy, pacemaker, prior incidences 
of neurological or musculoskeletal diseases, suffering from 
mental diseases, and lack of cooperation. 
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TABLE I.  DEMOGRAPHICS OF THE PATIENTS 
Patient 1 2 3 4 5 
Age 18 26 18 64 32 
Days since ABI 108 106 108 25 76 
Affected body side Left Right Right Right Right 
Type of ABI TBI TBI TBI Stroke TBI 
     TBI: traumatic brain injury 
ABI: acquired brain injury 
 
The protocol for the study was approved by the local ethical 
committee (ESDH 1-10-72-135-12) and the experiments 
were conducted in accordance with the declaration of 
Helsinki. 
Lokomat 
Lokomat was used to provide gait training. Prior to the first 
experimental session, the patients had at least one training 
session in Lokomat to familiarize them to the EMGT.  
At each session, the Lokomat exoskeleton, gait speed, and 
BWS were adjusted to fit the patient. The ankle straps were 
adjusted to have the patient’s ankle joint in neutral position. 
When the gait training was initiated, Lokomat supplied 
timing information, defining the start- and end of the stance 
phases. 
Functional electrical stimulation 
To stimulate the common peroneal nerve, a one-channel, 
computer-controlled stimulator (Noxitest, Danmark) and two 
surface electrodes were used. The cathode (Pals Platinum 
Round 3.2 cm, Axelgaard Ltd., USA) was placed above the 
common peroneal nerve, close to the fibular head on the 
patient’s most affected leg. The anode (Pals Platinum Oval 
4.0x6.4 cm, Axelgaard Ltd., USA) was placed on the 
proximal aspect of the TA muscle on the same leg. The 
rectangular monophasic stimulation had a pulse duration of 
300 µs and a frequency of 30 Hz. Adjustments regarding the 
location of the electrodes and the stimulation intensity were 
done in each session, based on the evoked motor response. 
FES was triggered using custom made software [13]. The 
duration of the stimulation period was controlled by the 
output signals from the Lokomat. The start signal 
corresponded to heel-strike of the contralateral leg and the 
end signal corresponded to the beginning of the stance phase 
of the most affected leg [13]. Consequently, rhe patient’s 
most affected side was stimulated during the push-off and 
swing phases of the gait cycle. 
Outcome measurements 
Electromyography (EMG) was recorded using a bipolar 
configuration. Two electrodes (Medicotest, Oelstykke, 
Denmark) were placed on the muscle belly of TA on the 
patient’s most affected leg and a third electrode of the same 
kind was placed on the tibial bone serving as reference. The 
recordings were amplified, based on the patient’s individual 
maximum voluntary contraction, band-pass filtered (10-500 
Hz, second order), sampled at 2 kHz, and saved. 
Kinematics of the ankle joint was recorded in the sagittal 
plane using an electronic goniometer (SG110/A, Biometrics 
Ltd., Gwent, UK). The goniometer was placed on the lateral 
side of the ankle of the most affected leg. Data was sampled 
at 2 kHz and saved.  
The output timing signals from Lokomat were also sampled 
at 2 kHz, saved, and used to detect the phases of the gait 
cycle in the later offline analysis. 
 
Experimental procedure 
Pre- and post-intervention evaluation 
Pre- and post-intervention evaluations were performed to 
assess the effect of training. The goniometer and EMG 
electrodes were mounted while the patients were seated. The 
patients then walked in Lokomat for 2-5 minutes before 
recording the ankle kinematics and TA EMG during 30 
steps. 
LokoFET training  
Patients had one hour set aside per session.  First, the FES 
stimulation intensity was determined starting at 10mA and 
adding steps of 2mA until adequate dorsiflexion was 
observed (≥10o) with the patient in sitting position. 
The Lokomat’s BWS system, exoskeleton, and treadmill 
were then adjusted. Immediately afterwards, the patients 
walked assisted by Lokomat and, if necessary, the 
stimulation intensity was adjusted until appropriate 
dorsiflexion was visually confirmed, or the stimulation 
intensity became intolerable. 
The patients received LokoFET training 2-3 times a week for 
3-4 weeks, giving a total of 6-8 treatments. 
The time spent on preparing for FES (e.g. placement of 
electrodes and adjusting stimulation intensity) before the 
actual training started was noted. The time spent on 
preparing Lokomat’s BWS and exoskeleton, and setting the 
speed of the treadmill was likewise noted. 
Data analysis  
The TA EMG activity in each step was assessed by the RMS 
in a window comprising the push-off and swing phases of the 
most affected leg. The RMS values corresponding to the 
individual steps in each session were then averaged. 
The kinematics of the ankle joint was assessed as the 
maximal angle variation in the same window as the EMG, 
but divided in two intervals due to the biphasic nature of the 
movement of the ankle joint. To assess the maximal 
plantarflexion, the window started at push-off and ended at 
the point of peak plantarflexion, indicating the end of the 
push-off phase. To assess maximal dorsiflexion, the window 
started at the point of peak plantarflexion and ended at heel-
contact.  
Statistical analysis 
Data were analyzed using a two-tailed paired t-test having 
time as the factor (pre- and post-intervention evaluation). If 
data was not normally distributed, a Wilcoxon signed rank 
test was performed. A significance level of p<0.05 was used. 
B. Acceptance of LokoFET in clinical practice 
To investigate the acceptance of LokoFET in clinical practice 
a semi-structured interview was performed and data was 
saved as transcripts [14]. The respondents for the semi-
structured interview were two of the physiotherapists who 
administered LokoFET.  
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Data analysis 
The analysis of the qualitative data was done using a 
conventional qualitative content analysis [15]. After reading 
the transcripts, the material was coded allowing for emerging 
themes to appear as sub-themes, resulting in a meaning 
condensation, and interpretation of the qualitative data [15]. 
 
III. RESULTS AND FINDINGS 
A. Test of LokoFET in clinical practice 
Out of the five patients originally included in the study, four 
patients completed the LokoFET training course. Patient 5 
was excluded due to low motor ability and low cognitive 
stamina making him unable to complete the LokoFET 
training within the one-hour limit per session. 
The mean stimulation intensity across patients was 
34.98±8.25 mA. The mean duration of the sessions was 
17.12±6.34 minutes. 10.35±3.83 and 35.91±6.00 minutes 
were spent for FES and Lokomat preparation, respectively. 
Effect of LokoFET training 
The TA EMG activity was significantly increased (73.34%) 
at the post-intervention evaluation, compared to the pre- 
intervention evaluation (paired t-test, p<0.05) (Fig. 1). 
The maximal dorsiflexion during the swing phase was 
significantly increased (66.78%) at the post-intervention 
evaluation, compared to the pre-intervention evaluation 
(paired t-test, p<0.02) (Fig. 2). 
The maximal plantarflexion during push-off was not changed 
at the post-intervention evaluation, compared to the pre-
intervention evaluation (paired t-test, p=0.67) (Fig. 3). 
 
 
Figure 1: TA EMG activity measured during the pre- and the post-training 
evaluations  
 
Figure 2: Maximal dorsiflexion measured during the pre- and the post-
training evaluations  
 
Figure 3: Maximal plantarflexion measured during the pre- and the post-
training evaluations  
B. Acceptance of LokoFET in clinical practice 
The therapists mentioned the FES element as a positive and 
active add-on treatment technique to the conventional EMGT 
therapy. However, it was also observed that in some 
LokoFET training sessions, FES resulted in dorsiflexion 
coupled with eversion of the ankle joint. 
Selective dorsiflexion was assessed by the therapists to be 
crucial for the acceptance of LokoFET in clinical practice. 
This is because the coupled dorsiflexion and eversion is not a 
part of the non-pathological gait pattern, which the therapists 
stride towards avoiding during gait training, especially 
during the sub-acute phase. Training in the application and 
use of FES for foot drop correction were therefore assessed 
to be crucial by the therapists. 
Time spent on FES preparation prolonged the usual time 
spent on preparation before training with Lokomat. The 
therapists argued that this could potentially harm the 
usefulness of LokoFET because many patients suffer from 
fatigue, hereby requiring a short preparation time in order to 
train before fatigue sets in.  
The therapists also argued that the mere use of Lokomat in 
the standard EMGT therapy (without FES) was highly 
complex on its own, especially when training heavily motor 
impaired patients. The introduction of FES could therefore 
add a level of complexity making them unable to use both 
Lokomat and FES. 
 
IV. DISCUSSION 
A. Test of LokoFET in clinical practice 
It was feasible for patients with different ABI to complete the 
LokoFET training in a clinical environment. The British 
Medical Research Council highlights the importance of 
feasibility studies evaluating the practical feasibility when 
introducing new interventions in everyday practice before 
testing them in larger clinical trials [16]. This study did not 
aim to show the effectiveness of LokoFET compared to 
conventional EMGT therapy or spontaneous remission. 
However, when comparing the pre- and post-intervention 
evaluation, both the TA EMG activity and the ankle joint 
kinematics (dorsiflexion) showed significant gains related to 
the foot drop impairment. 
In this study, the stimulation intensity was adjusted until 
appropriate dorsiflexion was visually confirmed, or the 
stimulation intensity became intolerable. Alternatively, the 
adjustment of the stimulation intensity could have been 
based on more precise kinematic information using 
electronic goniometers or other sensors external to the 
Lokomat. However, one of the goals of this FES add-on 
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solution was to be as simple to utilize as possible. The use of 
an external sensor would therefore have increased the 
complexity of the system. 
Weakness of ankle dorsiflexors is a known cause of foot drop 
[4]. Furthermore, reduced strength of the dorsiflexors has 
shown to be a primary determinant for slowed gait velocity 
and temporal asymmetry in stroke patients [17]. Increased 
TA EMG activity and dorsiflexion, as observed in this study, 
can therefore be interpreted as signs of recovery. 
The reason for combining Lokomat and FET was to provide 
more active training of the ankle joint to Lokomat training. 
Active, highly repetitive, and task-specific training has been 
shown important in creating better neurological rehabilitation 
outcomes [18]. LokoFET seemed to provide the conventional 
EMGT therapy with more active ankle joint training 
compared to EMGT alone, as in [13]. 
Additionally to the inhibition of dorsiflexion caused by the 
EMGT used in this study, the movement of the hip joint is 
restricted to the sagittal plane [8], which does not fully 
support a physiological gait movement. Future studies might 
benefit on using an EMGT, which allows both 
adduction/abduction and rotation of the hip joint. The 
LokoFET system uses a treadmill to provide gait therapy. A 
similar EMGT system using a robot-driven exoskeleton 
orthosis and over-ground walking could have been used 
instead [6]. However, over-ground walking might demand a 
better control of balance from the patient, leaving patients 
with severe impaired balance unable to perform this kind of 
therapy.  When comparing normal over-ground walking with 
treadmill walking, treadmill walking shows higher cadence, 
shorter swing phase, shorter step length and longer stance 
phase with a lower level of hip extension [19]. Treadmill 
walking is therefore somewhat different compared to over-
ground walking, which must be considered the norm. On the 
other hand, treadmill training allows for training in a small 
stationary environment, with a high level of control, making 
it easy to use measuring, support, and visual biofeedback 
equipment [19], which was desirable in the present case. 
To further evaluate the effectiveness of LokoFET, a larger 
clinical trial would be necessary. The current study has 
presented a feasible training protocol and provided grounds 
for sample size calculations for future clinical trials. 
B. Acceptance of LokoFET in clinical practice 
The FES element of LokoFET was found useful as an add-on 
treatment technique in the clinical practice, as a tool to 
provide the patients with active training of their foot drop. 
Perceived usefulness in the eyes of the healthcare personnel 
is a critical aspect for obtaining acceptance of a new 
technology [20]. The fact that the therapists found the FES 
element useful provides good basis for acceptance of 
LokoFET in the clinical practice. On the other hand, the 
observed eversion coupled with the desired dorsiflexion, 
impacted negatively on the perception of usefulness of 
LokoFET. This aspect was assessed to be critical, in order for 
LokoFET to be useful in clinical practice. Changing the 
stimulation location and reducing the stimulation intensity, 
could in many cases diminish the undesired eversion and 
more selective dorsiflexion could be produced. The use of 
electrode arrays with multiply active stimulation channels 
might in this context ease the identification of the optimal 
stimulation location [21].  
The undesired eversion could be caused by the higher 
stimulation intensities, which affect larger areas, depolarizing 
a larger amount of fibers of the superficial peroneal nerve, 
leading to increased activation of the peroneal muscle, which 
everts the ankle joint. Patients needing higher stimulation 
intensities (e.g. patients with severe foot drop, primarily 
caused by spasticity of the calf muscles) might therefore not 
be candidates for training with LokoFET or FES in general. 
Unfortunately, this study did not asses the spasticity or the 
passive mechanical resistance of the ankle joint of the 
patients before inclusion and therefore, no relation between 
the degree of foot-drop, the level of spasticity, and the 
stimulation amplitude could be made. 
The therapists also mentioned that time spent on preparation 
instead of training could result problematic for some patients 
who can easily get fatigued. Post-stroke fatigue is a common 
stroke symptom [22]. Using the abovementioned electrode 
arrays, might help reducing the time needed for preparation. 
However, the preparation time for Lokomat was far greater 
than that for FES, whereby the patient was placed in sitting 
position for the latter preparation procedure. A possible 
reduction of the Lokomat preparation time might therefore be 
more beneficial.  
The introduction of the FES element could result problematic 
for the therapists, especially when working with heavily 
motor impaired patients, due to the added complexity of 
operating both Lokomat and the FES system. In this study, 
FES was administered by a FES specialist and not by the 
therapists administering the EMGT therapy. Whether or not 
the added complexity of FES is a real problem is therefore 
unknown.  
Training of personnel in both the application of FES and 
EMGT therapy is therefore important in order to secure 
optimal muscle selectivity and time efficiency. Furthermore, 
care should be taken to include eligible patients based on 
their level of spasticity and fatigue. 
 
V. CONCLUSION 
This feasibility study showed that LokoFET was able to 
provide ABI patients with active training of their ankle joint 
and resulted in improvements related to their foot drop 
impairment. However, the effectiveness of LokoFET 
compared to conventional EMGT therapy is still unknown. 
Therapists perceived LokoFET as a useful tool in the 
rehabilitation of gait, pointing towards possible acceptance of 
the technology. However, muscle selectivity and the added 
complexity related to the FES element of the treatment were 
assessed to be critical for LokoFET to be useful in clinical 
practice.  
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